Response of mitochondrial function to hypothyroidism in normal and regenerated rat skeletal muscle.
Although thyroid hormones induce a well known decrease in muscle oxidative capacity, nothing is known concerning their effects on mitochondrial function and regulation in situ. Similarly, the influence of regeneration process is not completely understood. We investigated the effects of hypothyroidism on mitochondrial function in fast gastrocnemius (GS) and slow soleus (SOL) muscles either intact or having undergone a cycle of degeneration/regeneration (Rg SOL) following a local injection of myotoxin. Thyroid hormone deficiency was induced by thyroidectomy and propylthiouracyl via drinking water. Respiration was measured in muscle fibres permeabilised by saponin in order to assess the oxidative capacity of the muscles and the regulation of mitochondria in situ. Oxidative capacities were 8.9 in SOL, 8.5 in Rg SOL and 5.9 micromol O2/min/g dry weight in GS and decreased by 52, 42 and 39% respectively (P < 0.001) in hypothyroid rats. Moreover, the Km of mitochondrial respiration for the phosphate acceptor ADP exhibited a two-fold decrease in Rg SOL and intact SOL by hypothyroidism (P < 0.01), while mitochondrial creatine kinase activity and sensitivity of mitochondrial respiration to creatine were not altered. The results of this study demonstrate that hypothyroidism markedly altered the sensitivity of mitochondrial respiration to ADP but not to creatine in SOL muscles, suggesting that mitochondrial regulation could be partially controlled by thyroid hormones. On the other hand, mitochondrial function completely recovered following regeneration/degeneration, suggesting that thyroid hormones are not involved in the regeneration process per se.
Zoll
J
J
Unité de Bioénergétique et Environnement, Centre de Recherches du Service de Santé des Armies, La Tronche, France.
Ventura-Clapier
R
R
Serrurier
B
B
Bigard
A X
AX
D000818:Animals; D019069:Cell Respiration / Q000187:drug effects / Q000502:physiology*; D002950:Citrate (si)-Synthase / Q000378:metabolism; D003401:Creatine / Q000494:pharmacology; D003402:Creatine Kinase / Q000378:metabolism; D004195:Disease Models, Animal; D007037:Hypothyroidism / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D008931:Mitochondria, Muscle / Q000378:metabolism*; D018656:Muscle Fibers, Fast-Twitch / Q000378:metabolism*; D018657:Muscle Fibers, Slow-Twitch / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000293:injuries / Q000378:metabolism* / Q000503:physiopathology; D009929:Organ Size / Q000502:physiology; D010085:Oxidative Phosphorylation / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D012038:Regeneration / Q000502:physiology*; D012910:Snake Venoms / Q000494:pharmacology; D013965:Thyroidectomy; D014284:Triiodothyronine / Q000097:blood
D012910:Snake Venoms; D014284:Triiodothyronine; D002950:Citrate (si)-Synthase; D003402:Creatine Kinase; D003401:Creatine